ACM
ABBV icon

Advent Capital Management’s AbbVie ABBV Stock Holding History

Advent Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-50
Closed -$2K – 519
2015
Q1 		$2K Buy
+50
New +$3.02K ﹤0.01% 461

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advent Capital Management's ABBV Position: Q1 2026 in Review

Advent Capital Management held its AbbVie (ABBV) position steady in Q1 2026 at 15,000 shares worth $3.26M. The position accounts for 0.09% of the portfolio, ranked #140.

Advent Capital Management first reported a position in ABBV in Q1 2015 and has held it in 23 quarters since. The position peaked at $6M in Q1 2022. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Advent Capital Management held 15,000 shares of AbbVie worth $3.26M as of Q1 2026.
  • Advent Capital Management left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.09% of Advent Capital Management's portfolio in Q1 2026, its #140 holding.
  • Advent Capital Management first reported a position in AbbVie in Q1 2015 and has held it in 23 quarters since.
  • Advent Capital Management's AbbVie position peaked at $6M in Q1 2022.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Advent Capital Management's 13F filing for Q1 2026, filed 7 May 2026.